SAMINOR 2


The second survey of the Population-based Study on Health and Living Conditions in Regions with Sami and Norwegian Populations (SAMINOR 2) was conducted by the Centre for Sami Health Research at the Department of Community Medicine, UiT The Arctic University of Norway in 2012-2014.

Samisk flaggikon    Norsk flaggikon   

 

SAMINOR 2 was conducted in two stages. Stage 1 was a questionnaire survey conducted in 25 municipalities with Sami and Norwegian populations in Northern Norway and Trøndelag. The survey took place in the same regions as SAMINOR 1, but Sør-Varanger was included as a new municipality. In six of the municipalities, only a few districts were included. Stage 2 (the clinical survey) was conducted in ten selected municipalities that had all taken part in SAMINOR 1 and SAMINOR 2, Stage 1.

 

SAMINOR 2, Stage 1: The Questionnaire Survey

In January 2012, an eight-page questionnaire was sent to everyone aged 18-69 in the selected region, accompanied by an invitation letter (invitation letter in Norwegian and Northern Sami, invitation letter in Norwegian and Lule Sami, invitation letter in Norwegian and Southern Sami). The questionnaire was provided in Northern Sami, Lule Sami, and Southern Sami, in addition to Norwegian. The questionnaire could also be completed online (Norwegian only). The Centre for Sami Health Research used Statistics Norway to send out the questionnaires. Reminders (reminder in Norwegian and Northern Sami, reminder in Norwegian and Lule Sami, reminder in Norwegian and Southern Sami) were sent twice to non-responders at about six weeks and four months after the original invitation.

Municipalities invited to participate in stage 1:

Finnmark: 

Karasjok, Kautokeino, Porsanger, Tana, Nesseby, Lebesby, Alta, Loppa. Kvalsund  and Sør-Varanger.

Troms:

Kåfjord, Kvænangen, Storfjord, Lyngen, Skånland and Lavangen

Nordland:

Tysfjord, Evenes, Hattfjelldal (Hattfjelldal district), Grane (Majavatn district), Narvik (Vassdalen district) 

Nord-Trøndelag:

Røyrvik and parts of Namsskogan (Trones and Furuly) and Snåsa (Vinje)

Sør-Trøndelag:

Parts of Røros Municipality (Brekken)

Apart from Alta and Sør-Varanger, all municipalities had fewer than 4000 inhabitants.

 

 

Oversikt over kommuner invitert til SAMINOR trinn 1

Participation in Stage 1 (the SAMINOR 2 Questionnaire Survey)

 

 

Men

Women

Total

Age

No. invited

No. of participants

%

No. invited

No. of participants

%

No. invited

No. of participants

%

18-19

966

100

10.4

844

173

20.5

1 810

273

15.1

20-29

3 987

426

10.7

3 610

785

21.7

7 597

1 211

15.9

30-39

3 778

680

18.0

3 586

965

26.9

7 364

1 645

22.3

40-49

4 876

1 096

22.5

4 586

1 548

33.8

9 462

2 644

27.9

50-59

4 592

1 339

29.2

4 236

1 594

37.6

8 828

2 933

33.2

60-69

4 366

1 508

34.5

3 818

1 386

36.3

8 184

2 894

35.4

Total

22 565

5 149

22.8

20 680

6 451

31.2

43 245

11 600

26.8

 

For further details of SAMINOR 2 Stage 1 (the Questionnaire Survey), see this article:

Brustad M, Hansen KL, Broderstad AR, Hansen S, Melhus M. A population-based study on health and living conditions in areas with mixed Sami and Norwegian settlements – the SAMINOR 2 questionnaire study. Int J Circumpolar Health 2014, 73: 23147.

 

 



SAMINOR 2, Stage 2: The SAMINOR 2 Clinical Survey

The SAMINOR 2 Clinical Survey, also called the “Health and Lifestyle Survey”, was conducted by the Centre for Sami Health Research in 2012-2014 in ten selected municipalities, all of which participated in SAMINOR 1 and in Stage 1 of SAMINOR 2. This survey included a new questionnaire, some clinical examinations and blood sampling.

 

Municipalities selected for participation in SAMINOR 2, Stage 2

  • Skånland and Evenes (September-October 2012)
  • Karasjok (January-February 2013)
  • Kautokeino (February-March 2013)
  • Porsanger (April-May 2013)
  • Kåfjord (September-October 2013)
  • Storfjord (October-November 2013)
  • Nesseby and Tana (February-April 2014)
  • Lyngen (May-June 2014).

 

 

Implementation of the survey

Prior to the survey, cooperation was established with the authorities in each municipality. These provided suitable premises, freed municipal health workers to work in the clinical survey and offered other assistance. The Centre for Sami Health Research rented or borrowed premises in the various municipalities and established a research station for the period of the survey. Mostly, local health workers were freed to work at the research station. Seventy hired staff were involved in collecting the data.

The target group was the entire population aged 40–79, regardless of whether or not they participated in Stage 1. About one month in advance, a pamphlet was sent out by post, which contained information about the forthcoming health survey (pamphlet in Northern Sami, pamphlet in Kven). A few weeks later, a personal invitation was sent out, which included an information brochure (information brochure in Northern Sami), a scheduled appointment (appointment in Northern Sami) and a questionnaire. About halfway through the survey period, those who had not yet attended received a reminder in the post (reminder in Northern Sami).

The survey consisted of a clinical examination and blood tests. Participants were also asked to complete in advance a questionnaire they had been sent and bring it to the appointment. Participants aged 70–79 received a separate questionnaire designed for older people. There were thus two questionnaires used in Stage 2: one of eight pages for people aged 40–69 years (questionnaire in Norwegian, questionnaire in Northern Sami) and one of four pages for the age group 70–79 years (questionnaire in Norwegian, questionnaire in Northern Sami).

 

Clinical measurements 

Height, weight, hip and waist circumference, pulse and blood pressure were measured.

 

Blood samples

Non-fasting blood samples were taken. Long-term blood sugar (HbA1c) and haemoglobin levels were analysed on site. All participants were offered written results of the examinations at the station, including long-term blood sugar and haemoglobin levels. In the case of abnormal findings, participants were referred to their GP. Other samples were frozen and sent to UiT The Arctic University of Norway to be stored in the biobank. Lipids, biomarkers for diabetes, inflammatory reactions, iron status and some vitamins were analysed at the University Hospital of North Norway in autumn 2014. In spring 2016, vitamin D was analysed in Helsinki, Finland. Environmental toxins were also analysed in selected participants. The remaining blood samples were stored in the biobank for later analysis.

 

 

Participation in Stage 2 (the SAMINOR 2 Clinical Survey)

 

 

Men

Women

Total

Age

No. invited

No. of participants

%

No. invited

No. of participants

%

No. invited

No. of participants

%

40-44

867

255

29.4

836

388

46.4

1 703

643

37.8

45-49

907

283

31.2

795

364

45.8

1 702

647

38.0

50-54

883

319

36.1

777

406

52.3

1 660

725

43.7

55-59

897

372

41.5

848

481

56.7

1 745

853

48.9

60-64

970

481

49.6

872

535

61.4

1 842

1 016

55.2

65-69

930

488

52.5

817

504

61.7

1 747

992

56.8

70-74

591

336

56.9

550

333

60.5

1 141

669

58.6

75-79

424

213

50.2

491

246

50.1

915

459

50.2

Total

6 469

2 747

42.5

5 986

3 257

54.4

12 455

6 004

48.2

  

For further details of SAMINOR 2 Stage 2 (the Clinical Survey), see this article:

Broderstad, AR, Hansen S, Melhus M. The second clinical survey of the population-based study on health and living conditions in regions with Sami and Norwegian populations – the SAMINOR 2 Clinical Survey: Performing indigenous health research in a multiethnic landscape. Scandinavian J Public Health 2019: 1403494819845574. Published online 6 May 2019.

  

 

Feedback to municipalities


It is important to return knowledge to the people being researched. With this in mind, reports were prepared for all municipalities included in the SAMINOR 2 Clinical Survey with selected results from the municipality concerned. These results can contribute to health prevention and promotion and improve social services in the north. The SAMINOR Study can therefore be a useful contribution to meeting the requirements of the the Public Health Act. However, results depend on the level of participation. The more people who have participated, the more accurate will be the picture of public health in the various municipalities.



Financial/grant information:

The study received research funding from: 

  • The Northern Norway Regional Research Fund 
  • The county councils of Nordland, Troms and Finnmark 
  • Northern Norway Regional Health Authority (Helse Nord) 
  • The Sami Parliament 
  • The Sámi Norwegian National Advisory Unit on Mental Health and Substance Use (SANKS)   
  • The Ministry of Health and Care Services 

None of the above have conflicts of interest in the study.